New England Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Sell
56,979
-7,150
-11% -$1.67M 1.77% 11
2025
Q4
$13.3M Hold
64,129
1.74% 11
2025
Q3
$11.9M Buy
64,129
+375
+0.6% +$64.2K 1.55% 13
2025
Q2
$9.74M Buy
63,754
+290
+0.5% +$44.6K 1.52% 13
2025
Q1
$10.5M Buy
63,464
+7,325
+13% +$1.15M 1.71% 10
2024
Q4
$8.12M Sell
56,139
-6,850
-11% -$1.06M 1.39% 14
2024
Q3
$10.2M Buy
62,989
+11,845
+23% +$1.89M 1.59% 12
2024
Q2
$7.48M Sell
51,144
-385
-0.7% -$57.3K 1.24% 27
2024
Q1
$8.15M Buy
51,529
+2,225
+5% +$354K 1.26% 21
2023
Q4
$7.73M Buy
49,304
+2,368
+5% +$363K 1.24% 20
2023
Q3
$7.31M Buy
46,936
+4,750
+11% +$784K 1.2% 24
2023
Q2
$6.98M Buy
42,186
+6,400
+18% +$1.03M 1.01% 30
2023
Q1
$5.55M Sell
35,786
-2,075
-5% -$335K 0.83% 45
2022
Q4
$6.69M Sell
37,861
-1,775
-4% -$306K 0.12% 39
2022
Q3
$6.47M Buy
39,636
+2,795
+8% +$473K 0.11% 37
2022
Q2
$6.54M Buy
36,841
+1,480
+4% +$264K 0.11% 40
2022
Q1
$6.27M Sell
35,361
-700
-2% -$119K 0.1% 40
2021
Q4
$6.17M Buy
36,061
+1,500
+4% +$246K 0.09% 38
2021
Q3
$5.58M Buy
34,561
+3,034
+10% +$518K 0.1% 38
2021
Q2
$5.19M Buy
31,527
+900
+3% +$149K 0.09% 39
2021
Q1
$5.03M Buy
30,627
+550
+2% +$89K 0.1% 41
2020
Q4
$4.73M Buy
30,077
+700
+2% +$103K 0.1% 40
2020
Q3
$4.37M Sell
29,377
-850
-3% -$126K 0.1% 39
2020
Q2
$4.25M Sell
30,227
-2,500
-8% -$364K 0.1% 35
2020
Q1
$4.29M Buy
32,727
+1,620
+5% +$230K 0.1% 34
2019
Q4
$4.54M Sell
31,107
-350
-1% -$47.5K 0.07% 39
2019
Q3
$4.07M Hold
31,457
0.08% 46
2019
Q2
$4.38M Sell
31,457
-200
-0.6% -$27.7K 0.09% 39
2019
Q1
$4.42M Buy
31,657
+1,325
+4% +$177K 0.09% 40
2018
Q4
$3.91M Buy
30,332
+1,250
+4% +$174K 0.08% 38
2018
Q3
$4.02M Buy
29,082
+100
+0.3% +$13.3K 0.07% 41
2018
Q2
$3.52M Buy
28,982
+2,900
+11% +$362K 0.06% 44
2018
Q1
$3.34M Buy
26,082
+1,050
+4% +$142K 0.06% 40
2017
Q4
$3.5M Sell
25,032
-300
-1% -$41.8K 0.07% 39
2017
Q3
$3.29M Hold
25,332
0.07% 40
2017
Q2
$3.35M Sell
25,332
-300
-1% -$38.3K 0.11% 34
2017
Q1
$3.19M Buy
25,632
+3,382
+15% +$404K 0.05% 45
2016
Q4
$2.56M Buy
22,250
+1,500
+7% +$173K 0.07% 47
2016
Q3
$2.45M Buy
20,750
+1,600
+8% +$194K 0.09% 49
2016
Q2
$2.32M Buy
19,150
+100
+0.5% +$11.4K 0.08% 56
2016
Q1
$2.06M Sell
19,050
-4,300
-18% -$445K 0.06% 62
2015
Q4
$2.4M Buy
23,350
+1,200
+5% +$121K 0.06% 59
2015
Q3
$2.07M Buy
22,150
+2,400
+12% +$232K 0.05% 81
2015
Q2
$1.92M Buy
19,750
+500
+3% +$50.1K 0.05% 85
2015
Q1
$1.94M Buy
19,250
+2,750
+17% +$280K 0.05% 85
2014
Q4
$1.73M Hold
16,500
0.04% 89
2014
Q3
$1.76M Sell
16,500
-3,100
-16% -$322K 0.04% 93
2014
Q2
$2.05M Sell
19,600
-3,800
-16% -$384K 0.05% 96
2014
Q1
$2.3M Sell
23,400
-4,800
-17% -$445K 0.06% 82
2013
Q4
$2.58M Buy
28,200
+1,000
+4% +$92.2K 0.07% 81
2013
Q3
$2.36M Buy
27,200
+10,200
+60% +$915K 0.07% 77
2013
Q2
$1.46M Buy
+17,000
New +$1.44M 0.04% 79

Other funds holding JNJ

New England Asset Management's JNJ Position: Q1 2026 in Review

New England Asset Management reduced its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, selling an estimated $1.67M and leaving 56,979 shares worth $13.9M. The position accounts for 1.77% of the portfolio, ranked #11.

New England Asset Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • New England Asset Management held 56,979 shares of Johnson & Johnson worth $13.9M as of Q1 2026.
  • New England Asset Management sold 7,150 Johnson & Johnson shares in Q1 2026, an estimated $1.67M.
  • Johnson & Johnson made up 1.77% of New England Asset Management's portfolio in Q1 2026, its #11 holding.
  • New England Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on New England Asset Management's 13F filing for Q1 2026, filed 15 May 2026.